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CILIARY neurotrophic factor (CNTF) was originally characterized 
as a sUn'iYal factor for chick ciliary neurons in vitro 1• More 
recently, it was shown to promote the sUn'iYal of a variety of other 
neuronal cell typesl ") and to affect the differentiation of E7 chick 
sympathetic neurons by inhibiting their proliferation and by ioduc· 
ing the expression of yasoactiYe intestinal peptide immunoreac-
tiyity (VIP-IRt. In cultures of dissociated sympathetic neurons 
from newborn rats, CNTF induces cholinergic differentiation as 
shown by increased leyels of choline acetyltransferase (ChAT)!i. 
t To whom correspondence should be addressed, 
* Present address: Rea_Of! PharmaceutICals. Inc., T8fTYtown. New YOI1I., US" . 
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FIG, 1 a, COmplementary DNA cloning, and b, nucleotide and deduced amino· 
acid sequence of CNTF. The oligonucleotides used as primers are shown in 
c and their corresponding positions in the nucleotide sequence in b. Multiple 
cloning sites are indicated as lower ·case letters. In the case of degenerated 
codons we used IlPAC symbols. Underlined amino acids in b correspond to 
the peptide sequences obtained from tryptic (T1 .TS) and cyanogen bromide 
(CBI-4l fragments of CNTF. At the nucleotide level. sequences corresponding 
to the coding region are bold·faced and the polyadenylation signal sequence 
Is underlined. 
METHODS. Cultured rat astrocytes were grown for 3 weeks as described20, 
One day after final subculturing, total RNA was extracted from the cel1s21, 
Complementary DNA was synthesized using oligonucleotide 5 and reverse 
transcriptase of the Moloney murine lerJ<.aemia virus (Belhesda Research 
laboratories). The first strand of cDNA served as a template for amplifICation 
of specifIC segments of CNTF usjng pcW:2, Clone A was generated using 
This increase is paralleled by a reduction of tyrosine hydroxylase 
(TH) actiYity. Moreoyer, CNTF promotes the differentiation of 
bipotential 02A progenitor cells to type-2.astrocytes6 in virro . To 
help establish which, if any, of these functions CNTF exerts in 
vivo, it is necessary to determine its primary structure, cellular 
expression, deYelopmental regulation and localization. The com· 
plementary DNA--deduced amino-acid sequence and subsequent 
expression of cDNA clones covering the entire coding region in 
HeLa~ells indicate that CNTF is a cytosolic protein. This, 
together with its regional distribution and its deyelopmental 
expression, show that CNTF is not a target-deriyed neurotrophic 
factor. CNTF thus seems to exhibit neurotrophic and differenti-
ation properties only after becoming available either by cellular 
lesion or by an unknown release mechanism. 
CNTF was purified from adult rat sciati c nerve as described 
previouslyS, using an additional HPLC purification step (for 
details see legend to Table I). The amino·acid sequences of the 
va rious fragments determined by gas· phase microsequencing 
represented more than 50% of the protein. The peptide sequences 
thus obtained matched perfectl y with those deduced from cD NA 
cloning as shown in Fig. 1. 
To obtain R NA for molecula r cloning, we used cultures of 
rat brain cell s that previously had been shown to p roduce 
substant ial quantities of C NTF (ref. 7), After va rious polymerase 
chain react ion steps, the nucleotide sequences of clones A, B, 
C revealed a short 5' untranslated region of 77 base pai rs (bp) 
and an open reading frame o f 600 bp, predicting a protein 200 
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the degenerated primer-{)ligos 1 and 2: the PCR product was identifred with 
oligonucleotide 11, subcloned and sequenced by the dideoxynucleotide chain· 
termination method23. The nucleotide sequence thus obtained was used to 
synthesize primers 3 and 4 for amplifICation of cDNA ends according to 
Frohmann et al.2 .(o The cDNAs obtained were subcloned Into the Bluescript 
SK + vector (Stratagene) and sequenced (clones B and Cl, Oligonucleotide 
7 was derived from the sequence of a genomk: clone (Carrell. unpublished 
datal, This primer, together with oligonucleotide 6 was used to create clone 
D using essentially the same protocol as for clone C, except that we 
performed a G·tailing procedure Instead of T .taillng to generate 5'clones2s, 
The inserts of several clones were sequenced and shown to be Identical. 
PCR with newly synthesized cONA from astrocytes and oligonucleotides 9 
and 10 revealed a cDNA done covering the entire coding region. The cDNA 
thus obtained (Fig, 1a. clone El was used for expression in eukaryotk: cells, 
2 
amino acids lo ng with a 3' untranslated region of 436 bp, which 
ends in a poiy(A) tail (Fig. l b). The initiation site for translation 
was localized at position 78-80 of the nucleotide sequence. A 
SlOp codon located 5' to this initiation site at position 72-74 
and G residues in positions 75 and 81 fulfil the requirements 
for an adequa te translation initiation site, accordi ng to Kozak8 • 
Although the dibas ic (Arg-Arg) sequence in positions 13 
and 14 of the predicted sequence represent!' a potential post-
transla tio nal cleavage sile, the amino-acid composition of 
purified C NTF (Tab le I) does not favour such a cleavage: the 
amino acids phenylalanine, arginine and a lanine present in the 
N-terminal region are not reduced relative to other amino acids 
that are absent from this region (for example, iso leucine). 
Moreover, the predicted relative molecula r mass (M .) of 22,800 
(22.8K), corresponding to the 200-amino-acid sequence is in 
complete agreement with tha t estimated from PAGE analysis 
(22.S K) (rer. 6). Thus, the amino-acid sequence or CNTF shows 
the fea rures of a cytosolic protein ; that is, no signal peptide, no 
consensus sequences for glycosylation and only one cyste ine 
res idue at position 17. Comparison of the determined CNTF 
sequence with those o f the PIR and EMBL databases did not 
reveal significant simil arities with any other known protein. In 
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FIG, 2 Survival of cultured E8 chick ciliary neurons in the presence of 
supernatants and ex.tracts of transfected HeLa cells. Embryonic day·8 ciliary 
neurons were grown in the presence of supernatants (a) and extract s (b) 
of HeLa cells transfected with plasmid without insert (~) and plasmid 
containing CNTF cONA clone E in sense (0 ) and antisense orientation (D). 
METHODS. An expression vector with cytomegalo·promotor (gift of David 
Russell. Dallas) was used for subcloning a mature CNTF clone (Fig. la, clone 
E) In both orientations. Hela cells were used for transfections, as no basal 
ex.pression of survival.promoting activity for embryonic chick ciliary neurons 
could be detected in these cells. Each culture dish (lOO-mm diameter) was 
transfected with 10 ,u.g of vector by the DEAE-Dextran method26. After 48 h 
In culture the supernatants were removed, the cells washed three times 
with cold PBS buffer and lysed in a 5 mM phosphate buffer containing 30 mM 
Nacl (pH 7.0). After ultracentrifugation (100.000 g, 30 min) of the lysate. 
protein concentrations were determined and different concentrations of the 
supernatants were added to cultured E8·ciliary neurons. Surviving neurons 
were counted after 24 h of culture as described previously!!. Each point 
shows the mean of three determinations; bars represent the standard errors. 
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FIG. 3. Northern blot analysis of CNTF mRNA in tissues of the adult rat (a ) 
and in rat sciatic nerve during development (b). The abbreviations used are: 
UV. liver; KID, kidney; MC, muscle; SK. skin; SCI, sciatic nerve; SP, spinal cord: 
po, newborn rats; P4 , 4.day·old rats; P13, 13-day-old rats. 
METHODS, RNA was extracted from various rat tissues using the 
guanidinium thiocyanate extraction method27, Total RNA (30 J.'g. except RNA 
from muscle which was 50 ,u.g) was glyoxylated and electrophoresed through 
a 1.2% agarose ge128. In b, 25 IJ.g total RNA were loaded per lane. Known 
amounts of a 847 ·bp CNTF transcript (synthesized in vitro using the 
riboprobe system, PROtv1EGA) were also co·electrophoresed in separate 
lanes to permit quantification of CNTF mRNA in the samples. Following 
electrophoresis. RNA was vacuum·blotted to nylon filters (Hybond-N. Amer-
sham) and the f~ters were hybridized at 50 "C in 50% formamide28 using 
a randomly primed 32P_labelled cDf\lA probe29 covering the coding region of 
CNTF (600 bp). The filters were subsequently washed, exposed for 60 h to 
X·ray films and the autoradiograph was photographed. 
particular, there was no homology with nerve growth factor 
(NGF), brain-derived neurotrophic factor (BDNF)9 or fibrob-
last growth factor ( FGF) and purpurin, the survival activities 
of which overlap to some extent with those of C NTF 10•11• 
The likelihood that CNTF is a cytoplasmic protein is suppor-
ted by the observation that expression of a cDNA clone in HeLa 
ce ll s (Fig. 2) resulted in active CNTF being expressed but not 
being released into the culture medium. We cannot exclude 
however, that CNTF is secreted by any unconventional release 
mechanisms, as expression of clone E (Fig. la ) reveals a C-
terminally ex tended product. CNTF, rather, seems 10 be a 
molecule similar to FGF o r interleukin-l (lL- l ) both of which 
exert profound effects on cells but are cytoplasmic proteins. For 
FGF, no release mechanism has been estab lished 12, By contrast, 
IL-l has been demonstrated 10 be released from stimulated 
TABLE 1 Amino-acid composition of CNTF 
Purified CNTF Predicted from cDNA 
Asx 17.1 16 
Thr 9.9 12 
Ser 9.7 14 
Glx 30.5 30 
Pro n.d. 5 
Gly 11.7 11 
Ala 14.4 14 
Val 11.9 11 
Met 7.3 9 
lie 7.7 8 
Leu 24.5 26 
Tyr 4.3 4 
Phe 6.4 6 
His 6.2 8 
Lys 10.2 10 
Arg 11.1 11 
Cys n.d. 1 
Trp n.d. 4 
Amino-acid composition of CNTF. The amino-acid composition of purified 
CNTF corresponds to that predicted from the cDNA sequence. Purification 
and cleavage of CNTF: CNTF was purified as described6 but, in addition, after 
electroelution from preparative polyacrylamide gels, CNTF was applied to a 
C4-Widepore RP column (Baker, 7.75 x 100 mm) and eluted with 0.1% 
trifluoracetic acid and a gradient of acetonitrile. The biologically active protein 
eluted in one peak at 50-55% acetonitrile. Two-dimensional gel analysis 
showed that this protein migrated as a single spot6 . CNTF obtained by this 
method was concentrated in a Speedvac-concentrator to a final volume of 
50 JLI, diluted to 1 ml with HPLC-grade water and concentrated again to 
200 JLI. For cyanogen bromide cleavage, formic acid (final concentration 
70% v/v) and cyanogen bromide (10% w/v) were added to 30 JLg of purified 
CNTF. After 3 h at room temperature, 500 JLI H20 was added and the material 
concentrated to 50 JLI and applied immediately to the same reverse phase-
HPLC column. For tryptic cleavage, 30 JLg HPLC-purified CNTF were dried, 
redissolved in 50 JLI 0.1 M Tris HCI (pH 8.0) containing 10 mM CaCI2 and 
3 JLg tosyl phenylalanine chloromethyl ketone (TPCK)-treated trypsin (Sigma), 
and incubated overnight at 37°C. The resulting fragments were loaded on 
a C4-RP column (Baker) and eluted using the same conditions (flow rate 
1 ml min-1 , gradient 0-60% acetonitrile in 60 min, monitoring at 214 nm). 
Peaks were collected manually. The amino-acid sequences of the peptides 
were determined17 by use of automated gas-phase sequencing (Applied 
Biosystems 470A, 477A). The amino-acid composition of purified CNTF was 
determined after gas-phase hydrolysis18 of 5 J-Lg of CNTF on a Beckman 
6300 amino-acid analyser. n.d., Not done. 
macrophages by an unconventional mechanism after cleavage 
by a specific enzyme (convertase)13. Of particular interest is the 
recent finding that macromolecules may be exported from the 
yeast cytosol by carriers that show structural homologies with 
the multi drug-resistance glycoprotein in mammalian cells 14• 
Whether this glycoprotein can also act as a protein carrier in 
mammalian cells remains to be established. 
Northern blot analysis of the distribution of CNTF messenger 
RNA in tissues of adult rat revealed a single band -1.2 kilobases 
3 
(kb) in size. By far the strongest signal was present in northern 
blots of the sciatic nerve and a faint band was present in extracts 
of the spinal cord. But there was no detectable signal in mRNA 
of muscle and skin; that is, <2 pg of CNTF mRNA in 50 J.Lg 
and 30 J.Lg of total RNA respectively. The low levels of CNTF 
mRNA in muscle and skin indicate that the large amount of 
CNTF present in the sciatic nerve does not represent CNTF 
transported retrogradely from the periphery-as is the case for 
NGF-but represents locally synthesized CNTF. Moreover, the 
developmental time course of CNTF mRNA expression differs 
from that of NGF15• CNTF mRNA was undetectable in sciatic 
nerves of newborn rats, only becoming apparent by day 4 (Fig. 
3 b). The developmental time course of CNTF mRNA expression 
indicates that CNTF is not involved in the regulation of neuronal 
survival in the perinatal period, because target-regulated 
neuronal cell death 16,17 is already over by the time the increase 
in CNTF synthesis begins. 
CNTF differs from the known neurotrophic factors NGF and 
BDNF by the absence of a known constitutive release mechan-
ism, by the time course of its expression during development 
and by its regional distribution. It may be that CNTF has a 
physiological role as a differentiation factor, its neurotrophic 
function possibly only being exerted under pathophysiological 
conditions rather than during embryonic development. D 
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